Codexis, Inc. is a biotech company expected to break even in 2026 and post a profit of US$5.1m in 2027. Analysts project a 58% annual growth rate, though the company's high debt level poses investment risks.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing